← Back to feedRead original →
VERIFIEDET Finance·positive
Lupin gets USFDA tentative approval for prostate cancer treatment drug
AI Summary
- ·Lupin Ltd has received tentative approval from the US FDA for its generic enzalutamide tablets.
- ·The drug is used for the treatment of advanced prostate cancer.
- ·The approval covers multiple strengths: 40 mg, 80 mg, 120 mg, and 160 mg.